Global Nuclear Medicine/Radiopharmaceuticals Market

Global Nuclear Medicine/Radiopharmaceuticals Market is expected to reach USD 9.54 Billion by 2024 from USD 4.69 Billion in 2016 at CAGR of 9.28% (Detailed analysis of the market CAGR is provided in the report). Nuclear Medicine/Radiopharmaceuticals is used for diagnosis and treatment of various diseases that conventional medicines fail to achieve. Nuclear Medicine/Radiopharmaceuticals diagnose certain medical problems or treat certain diseases condition with various agents. Global Nuclear Medicine/Radiopharmaceuticals Market is segmented by type, procedural volume, application, and geography. Type segment is sub segmented as diagnostic nuclear medicine and therapeutic nuclear medicine/ radiopharmaceuticals. Application segment is divided as Diagnostic Applications, Therapeutic Applications and Other Therapeutic Applications. SPECT application segment is expected to register highest market growth during the forecast period, owing to SPECT presence of well-established imaging market and the extensive usage of SPECT radioisotopes for the diagnosis of cancer, cardiovascular diseases, thyroid, and neurological disorders. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. Increasing incidence and prevalence of cancer and cardiac ailments are trending the overall Global Nuclear Medicine/Radiopharmaceuticals Market. However, high cost of nuclear medicine equipment will restrain the market growth. North America is expected to dominate the Nuclear Medicine/Radiopharmaceuticals Market in forecast period followed by Europe and APAC. Presence of a well establish healthcare industry for the adoption of modern treatments and diagnostic procedures and rising awareness regarding the advantages that radiopharmaceuticals have to offer will fuel the Nuclear Medicine/Radiopharmaceuticals Market in North America region. Key Highlights: • Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Nuclear Medicine/Radiopharmaceuticals Market analysis and comprehensive segmentation with respect to the type, procedural volume, application, and geography to assist in strategic business planning • Global Nuclear Medicine/Radiopharmaceuticals Market analysis and forecast for five major geographies North America, Europe, Asia pacific, Middle East & Africa, Latin America and their key regions Research Methodology The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get unbiased idea of the market. This exercise was done at country level to get fair idea of the market in countries considered for this study. Later this country specific data was accumulated to come up with regional numbers and then arrive at global market value for Global Nuclear Medicine/Radiopharmaceuticals Market. Key Players in the Global Nuclear Medicine/Radiopharmaceuticals Market Are: • Advanced Accelerator Applications S.A. • Iba Molecular • Nordion, Inc. (A Subsidiary of Sterigenics International LLC.) • Eczacibasi-Monrol Nuclear Products • Siemens Healthcare • Sigma Aldrich Corporation • Bracco Imaging S.P.A • Bayer AG • Jubilant Pharma • Nordien, Inc. • Lantheus Medical Imaging, Inc. • GE Healthcare (A Fully-Owned Subsidiary of General Electric Company) • Mallinckrodt PLC • Cardinal Health, Inc. • Medtronic Plc. Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Radiopharmaceutical/Radioisotope Manufacturers and Distributors • Healthcare Institutions (Hospitals, Medical Schools, and Outpatient Clinics) • Contract Manufacturing Organizations (CMOs) • Contract research organizations (CROs) • Government Bodies Scope of the Report: Research report categorizes the Global Nuclear Medicine/Radiopharmaceuticals Market based on type, procedural volume, application, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Nuclear Medicine/Radiopharmaceuticals Market with key developments in companies and market trends. Global Nuclear Medicine/Radiopharmaceuticals Market, By Procedural Volume • Diagnostic Procedures o SPECT Radiopharmaceuticals o PET Radiopharmaceuticals • Therapeutic Procedures o Beta Emitters o Alpha Emitters o Brachytherapy Isotopes Global Nuclear Medicine/Radiopharmaceuticals Market, By Type • Diagnostic Nuclear Medicine o SPECT Radiopharmaceuticals o PET Radiopharmaceuticals • Therapeutic Nuclear Medicine/ Radiopharmaceuticals o Beta Emitters o Alpha Emitters o Brachytherapy Isotopes Global Nuclear Medicine/Radiopharmaceuticals Market, By Application • Diagnostic Applications o SPECT Applications o PET Applications • Therapeutic Applications o Thyroid o Bone Metastasis o Lymphoma o Endocrine Tumors • Other Therapeutic Applications Global Nuclear Medicine/Radiopharmaceuticals Market, By Geography • North America • Europe • Asia Pacific • Middle East & Africa • Latin America

Maximize Market Research Pvt. Ltd. Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk, Pune, Maharashtra 411051, India. This information is given by market research company(maximize market research)